golph3 modulates mtor signalling rapamycin sensitivity cancer 
genome-wide copy number analyses human cancers identified frequent 5p13 amplification several solid tumour types including lung % ovarian % breast % prostate % melanoma % using integrative analysis genomic profile region identify golgi protein golph3 candidate targeted amplification gain loss-of-function studies vitro vivo validated golph3 potent oncogene physically golph3 localizes trans golgi network interacts components retromer complex yeast linked target rapamycin tor signalling mechanistically golph3 regulates cell size enhances growth-factor-induced mtor also known frap1 signalling human cancer cells alters response mtor inhibitor vivo thus genomic genetic biological functional biochemical data yeast humans establishes golph3 new oncogene commonly targeted amplification human cancer capable modulating response rapamycin cancer drug clinical use 
